SCHEMBL25663116

SCHEMBL25663116

c1ccc2c(c1)sc1ncnc(-c3ccc(N(c4ccc(-c5ccc6nccnc6c5)cc4)c4ccc(-c5ccc6nccnc6c5)cc4)cc3)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CLK4 Q9HAZ1 1/20 0.33
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ LIMK1 P53667 1/20 0.31
▸ ADORA2A P29274 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663258 0.90 PIK3CA (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663102 0.89 NPC1 (0.44) ALDH1A1CYP3A4PIK3CDPIK3CAPIK3CB
SCHEMBL25663106 0.89 NPC1 (0.35) MEN1ALDH1A1CYP1A2CYP3A4CASP1
SCHEMBL25663259 0.85 PIK3CD (0.34) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663121 0.85 — —
SCHEMBL25663493 0.84 TGFBR1 (0.34) TGFBR1PIK3CA
SCHEMBL25663260 0.83 PIK3CD (0.46) MEN1ALDH1A1LMNATP53CYP1A2
SCHEMBL25663109 0.83 TGFBR1 (0.39) TGFBR1MEN1ALDH1A1CYP3A4KMT2A
SCHEMBL25663119 0.83 TDO2 (0.40) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663160 0.83 LIMK1 (0.42) PIK3CALIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 TGFBR1 1649/4885MEN1 1967/4885ALDH1A1 3072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback